Form D · Biotechnology
PetVivo Holdings, Inc.
Edina, MN · CIK 0001512922
Offering snapshot reported Sep 28, 2017 · SEC filing
- Reported sold
- $391K Offering amount: $525K
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jul 26, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 28, 2017 | Initial | $391,000 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-295592
Source: Form D, filed Sep 28, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David D. Deming | Director |
| John F. Dolan | Director, Executive |
| Wesley C. Hayne | Director, Executive |
| John Lai | Director, Executive |
| David B. Masters | Director, Executive |
| Randall A. Meyer | Director, Executive |
| Peter Vezmar | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5251 Edina Industrial Blvd
Edina, MN, 55437
Edina, MN, 55437